| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 93016 |
(R)-tert-Bu4-DOTAGA；817562-90-6 |
150 |
wyh |
2024-11-22 |
| 93017 |
DOTA-Bevacizumab DOTA-贝伐单抗 |
148 |
zcy |
2024-11-22 |
| 93018 |
10-[2-[(3,5-二羧基苯基)氨基]-2-氧乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸，三氟乙酸盐 |
134 |
wyh |
2024-11-22 |
| 93019 |
DOTA接枝N-乙烯基吡咯烷酮-丙烯醛P(VP-Ac)共聚物 DOTA-VP-Ac |
151 |
zcy |
2024-11-22 |
| 93020 |
DOTA-HYNIC-IPSMA |
150 |
wyh |
2024-11-22 |
| 93021 |
PEG-GO 聚乙二醇化超小GO氧化石墨烯的二维纳米材料 |
370 |
zcy |
2024-11-22 |
| 93022 |
CAS1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA |
116 |
zyl |
2024-11-22 |
| 93023 |
(S)-N-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYL)-6-(METHYL(3-(PIPERAZIN-1-YL)PROPYL)AMINO)QUINOLINE-4-CARBOXAMIDE |
146 |
wyh |
2024-11-22 |
| 93024 |
DOTA(Tris)-EA-TEG-NH2-CBZ DOTA(Tris)-乙胺(EA)偶联四甘醇(TEG) |
246 |
zcy |
2024-11-22 |
| 93025 |
DOTA-octreotide,大环配体奥曲肽 |
173 |
zyl |
2024-11-22 |
| 93026 |
N2-Acetyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-lysyl-L-prolyl-N2-methyl-L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-3-methyl-L-valyl-L-leucine |
136 |
wyh |
2024-11-22 |
| 93027 |
DOTA-Ts29.2 DOTA偶联单克隆抗体Ts29.2 |
163 |
zcy |
2024-11-22 |
| 93028 |
DOTA-FAMP α螺旋肽偶联DOTA大环配体 |
145 |
zcy |
2024-11-22 |
| 93029 |
DOTA-NT8-13(靶向NTR1) |
154 |
zcy |
2024-11-22 |
| 93030 |
DOTA Conjugated JM#21 derivative 7 ；3033865-40-3 |
165 |
wyh |
2024-11-22 |
| 93031 |
4-Aminobutyl-DOTA-tris(t-butyl ester) Hexafluorophosphate |
128 |
wyh |
2024-11-22 |
| 93032 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
129 |
wyh |
2024-11-22 |
| 93033 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
125 |
wyh |
2024-11-22 |
| 93034 |
DOTA-MC1RL 1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸缀合MC1R特异性支架 |
180 |
zcy |
2024-11-22 |
| 93035 |
钆布醇杂质20 ；229312-34-9 |
181 |
wyh |
2024-11-22 |
| 93036 |
DOTA-[Nle]-cCCK 科研定制 |
219 |
zcy |
2024-11-22 |
| 93037 |
DOTA-(COOt-Bu)3-CH2-Alkynyl ；1189194-64-6 |
143 |
wyh |
2024-11-22 |
| 93038 |
FITC-PEG2-TATE ；1027160-33-3 |
160 |
wyh |
2024-11-22 |
| 93039 |
DOTA-peg4-LLP2AVLA-4 齐岳定制 |
160 |
zcy |
2024-11-22 |
| 93040 |
蛙皮素肽功能化金纳米颗粒 BBN-AuNPs |
174 |
zcy |
2024-11-22 |
| 93041 |
RGD-DOTA的结构特点 |
194 |
wyh |
2024-11-22 |
| 93042 |
DOTA tris(TBE)-amido-dPEG-bromoacetamide |
159 |
wyh |
2024-11-22 |
| 93043 |
DOTA-PEG-OPSS-AuNP DOTA-PEG-邻吡啶基二硫化物修饰纳米金纳米粒子 |
173 |
zcy |
2024-11-22 |
| 93044 |
DOTA-PEG(23)-MAL*2TFA |
150 |
wyh |
2024-11-22 |
| 93045 |
DOTA偶联PSMA抑制剂 DOTA-PSMA |
166 |
zcy |
2024-11-22 |
| 93046 |
DOTA-PEG(11)-bromoacetamide*2TFA |
163 |
wyh |
2024-11-22 |
| 93047 |
Gn-PAMAM-(TmDOTA(-))(x)(其中n = 1-4，x = 6-39) 齐岳定制 |
165 |
zcy |
2024-11-22 |
| 93048 |
DOTA-(AF)SAv 1，4，7，10-四氮杂环十二烷-N，N′，N″，N″-四乙酸(DOTA)-(AF)SAv |
157 |
zcy |
2024-11-22 |
| 93049 |
PAMAM-DOTA DOTA缀合PAMAM树状大分子 |
186 |
zcy |
2024-11-22 |
| 93050 |
1374865-01-6；10-[2-[[3-(11,12-二脱氢二苯并[B,F]氮杂环辛-5(6H)-基)-3-氧代丙基]氨基]-2-氧代乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸 |
183 |
wyh |
2024-11-22 |
| 93051 |
DOTA-(D-Glu)6-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 齐岳定制 |
174 |
zcy |
2024-11-22 |
| 93052 |
DOTA唑来膦酸盐 ，1908409-18-6 ，DOTA Zoledronate |
168 |
wyh |
2024-11-22 |
| 93053 |
DOTA-C225-AuNPs DOTA修饰西妥昔单抗偶联金纳米颗粒 |
243 |
zcy |
2024-11-22 |
| 93054 |
FAP结合肽大环化合物；2581741-18-4 |
309 |
wyh |
2024-11-22 |
| 93055 |
DOTA-DGlu-Ala-Tyr DOTA偶联受体特异性肽 |
152 |
zcy |
2024-11-22 |
| 93056 |
三（叔丁氧羰基甲基）DOTA氢溴酸盐；137076-54-1 |
171 |
wyh |
2024-11-22 |
| 93057 |
DOTA-h173 双功能螯合剂DOTA偶联h173 |
153 |
zcy |
2024-11-22 |
| 93058 |
DOTA-四聚乙二醇-二苯并环辛炔；DOTA-PEG4-DBCO |
236 |
wyh |
2024-11-22 |
| 93059 |
BSH-3R-DOTA-(64)Cu BSH-3R偶联1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸(DOTA) |
155 |
zcy |
2024-11-22 |
| 93060 |
DOTA-三(酸) - 酰氨基-DPEG(R)23-马来酰亚胺 |
191 |
wyh |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询